Steven Cohen’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Steven Cohen’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.09M	Sell	269,814 -62,311	-19%	-$1.77M	0.01%	1419
2026 Q1	$9.96M	Sell	332,125 -154,084	-32%	-$5.1M	0.01%	1258
2025 Q4	$15.9M	Buy	486,209 +42,340	+10%	+$1.37M	0.02%	1052
2025 Q3	$15.4M	Buy	443,869 +102,369	+30%	+$3.27M	0.03%	642
2025 Q2	$9.56M	Buy	+341,500	New	+$9.16M	0.02%	751
2024 Q2	–	Sell	-53,700	Closed	-$1.73M	–	2075
2024 Q1	$1.73M	Sell	53,700 -100,949	-65%	-$3.75M	﹤0.01%	1309
2023 Q4	$6.29M	Sell	154,649 -18,651	-11%	-$686K	0.02%	840
2023 Q3	$5.99M	Sell	173,300 -707,368	-80%	-$27.5M	0.02%	827
2023 Q2	$35.8M	Buy	880,668 +165,068	+23%	+$6.73M	0.11%	242
2023 Q1	$27.7M	Buy	715,600 +660,500	+1,199%	+$27.2M	0.09%	277
2022 Q4	$2.45M	Buy	55,100 +41,100	+294%	+$1.73M	0.01%	903
2022 Q3	$597K	Buy	+14,000	New	+$717K	﹤0.01%	1135
2022 Q2	–	Sell	-509,800	Closed	-$31.6M	–	1477
2022 Q1	$31.6M	Sell	509,800 -254,100	-33%	-$15.6M	0.13%	218
2021 Q4	$42.1M	Buy	763,900 +646,000	+548%	+$33.7M	0.17%	164
2021 Q3	$6.2M	Sell	117,900 -594,256	-83%	-$35.3M	0.03%	616
2021 Q2	$49.1M	Buy	712,156 +246,678	+53%	+$18.8M	0.22%	114
2021 Q1	$35.9M	Buy	465,478 +206,278	+80%	+$19M	0.17%	162
2020 Q4	$25.7M	Buy	+259,200	New	+$31.7M	0.13%	220
2016 Q1	–	Sell	-63,600	Closed	-$4M	–	768
2015 Q4	$4M	Buy	+63,600	New	+$3.25M	0.03%	449

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Steven Cohen's LKFT Position: Q2 2026 in Review

Steven Cohen reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 19% in Q2 2026, selling an estimated $1.77M and leaving 269,814 shares worth $8.09M. The position accounts for 0.01% of the portfolio, ranked #1419.

Steven Cohen first reported a position in LKFT in Q4 2015 and has held it in 19 quarters since. The position peaked at $49.1M in Q2 2021. 77 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

Steven Cohen held 269,814 shares of Lakefront Biotherapeutics American Depositary Shares worth $8.09M as of Q2 2026.
Steven Cohen sold 62,311 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $1.77M.
Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1419 holding.
Steven Cohen first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and has held it in 19 quarters since.
Steven Cohen's Lakefront Biotherapeutics American Depositary Shares position peaked at $49.1M in Q2 2021.
77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.